|
Treatment of Fe(ClO4)2o6H2O or Fe(ClO4)3o9H2O with a benzimidazolyl-rich ligand, N,N,N',N'-tetrakis[(1-methyl-2-benzimidazolyl)methyl]-1,2-ethanediamine (medtb) in alcohol/MeCN give a mononuclear ferrous complex, [FeII(medtb)](ClO4)2oCH3CNoCH3OH (1), and four non-heme alkoxide-iron(III) complexes, [FeIII(OMe)(medtb)](ClO4)2oH2O (2, alcohol = MeOH), [FeIII(OEt)(Hmedtb)](ClO4)3oCH3CN (3, alcohol = EtOH), [FeIII(OPrn)(Hmedtb)](ClO4)3o- nPrOHo2CH3CN (4, alcohol = n-PrOH), and [FeIII(OBun)(Hmedtb)](ClO4)3o3CH3CNoH2O (5, alcohol = n-BuOH), respectively. The alkoxideiron(III) complexes all show 1) a Fe(III)?-OR center (R = Me, 2; Et, 3; nPr, 4; nBu, 5) with the FeO bond distances in the range of 1.781-?1.816 , and 2) yellow color and an intense electronic transition around 370 nm. The alkoxide-iron(III) complexes can be reduced by organic compounds with cis,cis-1,4-diene moiety via the hydrogen atom abstraction reaction (HAAR). |
|
Keywords:alkoxide complexes; crystal structure; HAAR |
|